Fuda Cancer Hospital
Immunotherapy for breast cancer in China typically costs from $22,500 to $82,000. The final price depends on the drug origin, hospital tier, and required cycles. Patients save approximately 25% compared to the US, where costs average $70,000. Standard inclusions often cover the medication, basic diagnostics, and specialist consultations in major medical hubs like Guangzhou, Shanghai, and Beijing.
Bookimed Expert Insight: Choosing specialized centers like Fuda Cancer Hospital provides access to JCI-accredited care. This facility has treated over 30,000 international patients using advanced cryosurgery and immunotherapy. Combining these minimally invasive therapies often yields better results for late-stage cases. While public hospitals are cheaper, private centers offer dedicated international departments. This ensures seamless communication and faster access to newest drug protocols.
| China | Turkey | Austria | |
| Immunotherapy for breast cancer | from $22,500 | from $9,500 | from $35,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy for breast cancer upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy for breast cancer and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy for breast cancer journey.
Day 1 - Arrival
Day 2 - Pre-Operation
Day 3 - Immunotherapy
Day 4 - Post-Operation
Week 1 to Week 3 - Rehabilitation
Week 4 to Week 6 - Rehabilitation
Please note that each patient reacts differently to immunotherapy. Therefore, this guide might not perfectly correspond to your individual journey. Always consult with your medical team for personalized information.
The doctor is a renowned expert in minimally invasive cryosurgery for cancer, serving as President and chief surgeon at Fuda Cancer Hospital since 2001. With a focus on oncology and minimally invasive procedures, the doctor has performed nearly 10,000 cryosurgeries and 500 NanoKnife procedures, treating patients aged 4 to 94.
Graduating from The Fourth Military Medical University with a specialty in thoracic and cardiac surgery, the doctor has contributed significantly to the field with over 100 published papers. Recognized with awards for outstanding contributions to cryosurgery, the doctor holds vice-presidential roles in both the Asian and International Societies of Cryosurgery.